Leadless Implantable Cardioverter Defibrillator

• US 20080294210A1
• Filed: 05/04/2005
• Published: 11/27/2008
• Est. Priority Date: 05/04/2004
• Status: Abandoned Application

• Current Assignee: University of Rochester
• Original Assignee: University of Rochester
• Inventors: Rosero, Spencer
• Application Number:
  US11/579,530
• Publication Number:
  US 20080294210A1
• Time in Patent Office: Days
• US Class Current: 607/5
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/372 Arrangements in connection with the implantation of stimulators
• CPC Class Codes: A61N 1/37288 Communication to several implantable medical devices within one patient
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

A leadless implantable cardioverter defibrillator (5) for treatment of sudden cardiac death includes a controller and at least one remote module. The defibrillator does not require transvenous/vascular access for intracardiac lead placement. The controller is leadless and uses subcutaneous tissue in proximity of the chest and abdomen for both sensing and defibrillation. The controller and one or more remote sensors sense a need for defibrillation and wireless communicate with the controller. The controller and one of the sensors discharge a synchronized defibrillation pulse to the surrounding subcutaneous tissue in proximity to the heart.

Claims

1. A leadless implantable defibrillator comprising a controller having a controller sensor for sensing patient conditions, a controller electrode for imparting a stimulation to the patient, and a controller wireless communicator, and further comprising at least one remote module having a remote sensor, a remote electrode, and a remote wireless communicator for wirelessly communicating with the controller wireless communicator.

2. The defibrillator of claim 1, wherein said remote wireless communicator and said controller wireless communicator communicate with one another using subcutaneous tissue as a communication medium.

3. The defibrillator of claim 1, wherein the controller wireless communicator comprises a wireless transmitter and the remote wireless communicator comprises a wireless receiver, wherein said wireless transmitter wirelessly transmits a signal to said wireless receiver.

4. The defibrillator of claim 1, wherein said controller is located in subcutaneous tissue in proximity to the chest and abdomen and said at least one remote module is located in the subcutaneous tissue.

5. The defibrillator according claim 1, wherein at least two remote modules are positioned, subcutaneously, around the thorax of the subject and communicate via radio frequency signals with the defibrillator.

6. The defibrillator according to claim 1, wherein the controller sensor and the remote sensor communicate sensed information to the controller and the controller determines whether there is a need for defibrillation.

7. The defibrillator according to claim 1, wherein the controller includes a first antennae.

8. The defibrillator according to claim 7, wherein the at least one remote module includes a second antennae.

9. A cardiac defibrillator comprising:

a controller implanted in the subcutaneous tissue of a patient in proximity to the subject'"'"'s chest and abdomen, a remote module implanted in the subcutaneous tissue of the patient, said controller having a wireless transmitter for wirelessly transmitting a signal from said controller to said remote module.

10. The defibrillator according to claim 9, wherein said defibrillator is leadless.

11. The defibrillator according to claim 9, wherein the signal is transmitted using the subcutaneous tissue as a communication medium.

12. The defibrillator according to claim 9, wherein the signal is transmitted via radio frequency.

13. The defibrillator according to claim 9, wherein said remote module includes a sensor for sensing a patient condition.

14. The defibrillator according to claim 9, wherein said remote module includes an electrode for imparting a defibrillation pulse to the patient.

15. A method for defibrillating the heart of a patient, the method comprising:

implanting a controller in the subcutaneous tissue in proximity to the chest and abdomen;

implanting a remote module subcutaneously in a posteriolateral location in the left chest area of the patient;

sensing a patient condition at the remote module and at the controller;

wirelessly transmitting the patient condition from the remote module to the controller;

determining at the controller when defibrillation of the heart is required based on the sensed patient conditions;

wirelessly transmitting a defibrillation signal from the controller to the remote module in response to determining when defibrillation of the heart is required; and

applying a defibrillation pulse by the controller and the remote module in response to receiving the defibrillation signal.

16. A leadless implantable apparatus for the treatment of sudden cardiac death of a subject wherein the subcutaneous tissue in proximity to the chest and abdomen is used for both sensing and defibrillation, comprising:

a controller located in the subcutaneous tissue;

a remote module located subcutaneously in the upper right quadrant of the subject'"'"'s chest and in radio frequency communication with the controller; and

a microthin patch located in a posteriolateral position in the upper left quadrant of the chest with an electrical wire connected to the controller.

17. The apparatus according to claim 16, wherein the microthin patch includes an electronic circuit for applying a voltage across the subcutaneous tissue in response to an electrical signal from the defibrillator.